Macrolides for the treatment of Pseudomonas aeruginosa infections?
Howe
R A
RA
Public Health Laboratory, Bristol Royal Infirmary, UK.
Spencer
R C
RC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D018942:Macrolides; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000276:immunology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000276:immunology / Q000472:pathogenicity; D012270:Ribosomes / Q000187:drug effects / Q000502:physiology; D014774:Virulence / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D018942:Macrolides